NPSA reissues Methotrexate guidance

July 2006

The National Patient Safety Agency (NPSA) has reissued guidance to the NHS in England and Wales to reinforce guidelines to reduce the risk of patient harm associated with the incorrect use of oral methotrexate.
BSR worked in collaboration with the NPSA and the British Association of Dermatologists over the last year to review the core patient information leaflet and monitoring document.